How the Framingham 10-Year CVD Risk Score Works
This calculator implements the Framingham General Cardiovascular Disease Risk Score, published by D'Agostino RB Sr. and colleagues in Circulation (2008;117:743-753). It is a sex-specific regression equation, derived from the long-running Framingham Heart Study, that estimates the probability that a person will have a first "hard" cardiovascular event — heart attack, stroke, heart failure, or peripheral artery disease — within the next 10 years. It uses seven inputs: sex, age, total cholesterol, HDL ("good") cholesterol, systolic blood pressure, whether that blood pressure is treated with medication, current smoking status, and diabetes status. Because it is not a diagnosis, this tool is meant to inform a conversation with a healthcare provider, not replace one.
How the calculation works
The model multiplies the natural log of age, total cholesterol, HDL cholesterol and systolic blood pressure (using a larger coefficient if treated) by sex-specific coefficients, adds fixed amounts for current smoking and diabetes, subtracts a sex-specific constant (23.9802 for men, 26.1931 for women), and converts the result to a 10-year risk as 1 − S0exp(sum − constant), with baseline survival S0 = 0.88936 (men) or 0.95012 (women). Coefficients are the published lipids-model values from the Framingham Heart Study (source). Because this is the continuous equation, results change smoothly rather than in point steps.
Understanding your risk category and next steps
A resulting 10-year risk below 10% is generally considered low, 10-19% is intermediate, 20-29% is high, and 30% or higher is very high, following standard cardiovascular risk stratification conventions. Higher categories typically prompt a closer look at lifestyle factors — diet, exercise, smoking cessation — and a discussion with a clinician about whether cholesterol-lowering or blood-pressure medication is appropriate. This score is educational: it does not know your family history, kidney function, inflammatory markers, or other factors a clinician may weigh.
Limitations of this tool
The score is validated only for adults ages 30-79 and was derived primarily from a White, New England population studied decades ago, so it can under- or over-estimate risk in other populations. Newer tools — the ACC/AHA Pooled Cohort Equations and the 2023 PREVENT equations — are now the guideline-recommended calculators for statin-therapy decisions in US clinical practice and may better reflect contemporary, more diverse populations. Use this calculator for general education and as a conversation starter, and always confirm treatment decisions with a licensed healthcare provider.